An Executive Summary of The Hodges Review

April 2022

The Food Standards Agency has published a list of the first CBD products available for sale in the UK, with more than 3,500 products making the cut.

March 2022

Episode 9: The importance of a new approach to cannabis Listen now (20 min) | We explore the importance of the upcoming Hodges Review of UK Public Policy & Regulatory Stewardship of the Legal Cannabis…
A new wide ranging commission to review regulation and public policy relating to the UK’s legal cannabis industry.
Episode 8: The Decalogue Review Listen now | We hear from the authors of our recent Decalogue paper, hosted by Róisín Delaney

February 2022

10. Reforming the Proceeds of Crime of ActOur final paper in the Decalogue abstract series is written by Dylan Kennett, Senior Associate at DLA Piper Reforming the Proceeds of Crime of A…
9. Germany | Europe’s Cannabis FrontierIs Germany fast becoming Europe’s cannabis frontier? Alfredo Pascual, an Investment Analyst with Seed Innovations explores exactly this in our ninth…

January 2022

8. Policing illicit medicinal cannabisOur eighth paper for Decalogue is written by cannabis campaigner, advocate and patient Carly Barton.
7. Can extending access to medicinal cannabis address health inequalities?The seventh paper, is written by Dr Ayesha Mian. Dr Mian is a junior doctor working in the NHS and has a background in drug policy reform.
6. Equal Treatment | CBMP’s & SpecialsThe sixth paper from ten in our Decalogue pamphlet comes from Jonathan Hodgson, CEO of Rokshaw Laboratories & Pierre van Weperen, MD at Grow Group
5. A Risk-based Approach to CannabisA Risk-based Approach to Cannabis was written by Hari Guliani, the Head of Columbia Care International
10 Years On: What we Achieved in Medicinal CannabisThe fourth paper in our Decalogue series is written by Pierre van Weperen, MD of Grow Group